Stenting of an unprotected left main coronary artery stenosis in a cardiac transplant patient

W Kong1, M R Le May, M Labinaz

  • 1Ottawa Heart Institute, Ottawa, Canada.

Insights

Successful stenting of the left main coronary artery in a cardiac transplant patient with allograft vasculopathy offers hope for improved outcomes. A 16-month follow-up showed a patent stent and no clinical events, suggesting a viable treatment option.

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Interventional Cardiology

Background:

  • Cardiac allograft vasculopathy (CAV) is the primary cause of late mortality in heart transplant recipients.
  • Retransplantation is often limited by donor availability and poorer outcomes compared to initial transplants.
  • Percutaneous coronary intervention, specifically stenting, is an emerging option for managing CAV.

Observation:

  • A case of successful stenting of an unprotected left main coronary artery stenosis in a heart transplant recipient is presented.
  • The procedure was performed under cardiopulmonary support.
  • The patient had significant stenosis within the context of cardiac allograft vasculopathy.

Findings:

  • A 16-month follow-up angiogram confirmed the stent remained patent.
  • No evidence of in-stent restenosis was observed.
  • The patient experienced no clinical events during the follow-up period.

Implications:

  • Stenting may be a feasible and effective treatment for unprotected left main coronary artery stenosis in cardiac transplant patients with CAV.
  • This approach could offer an alternative to retransplantation, addressing donor limitations.
  • Further randomized trials are needed to validate these findings and establish definitive treatment guidelines.